GB201411616D0 - Diagnosis and treatment of neurodegenerative disorders - Google Patents

Diagnosis and treatment of neurodegenerative disorders

Info

Publication number
GB201411616D0
GB201411616D0 GBGB1411616.4A GB201411616A GB201411616D0 GB 201411616 D0 GB201411616 D0 GB 201411616D0 GB 201411616 A GB201411616 A GB 201411616A GB 201411616 D0 GB201411616 D0 GB 201411616D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
treatment
neurodegenerative disorders
neurodegenerative
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1411616.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GBGB1411616.4A priority Critical patent/GB201411616D0/en
Publication of GB201411616D0 publication Critical patent/GB201411616D0/en
Priority to PCT/GB2015/051899 priority patent/WO2016001644A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
GBGB1411616.4A 2014-06-30 2014-06-30 Diagnosis and treatment of neurodegenerative disorders Ceased GB201411616D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1411616.4A GB201411616D0 (en) 2014-06-30 2014-06-30 Diagnosis and treatment of neurodegenerative disorders
PCT/GB2015/051899 WO2016001644A1 (en) 2014-06-30 2015-06-29 Diagnosis and treatment of neurodegenerative disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1411616.4A GB201411616D0 (en) 2014-06-30 2014-06-30 Diagnosis and treatment of neurodegenerative disorders

Publications (1)

Publication Number Publication Date
GB201411616D0 true GB201411616D0 (en) 2014-08-13

Family

ID=51410366

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1411616.4A Ceased GB201411616D0 (en) 2014-06-30 2014-06-30 Diagnosis and treatment of neurodegenerative disorders

Country Status (2)

Country Link
GB (1) GB201411616D0 (en)
WO (1) WO2016001644A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113295658A (en) * 2021-03-22 2021-08-24 闽江学院 Method for detecting tyrosinase activity
GB202214417D0 (en) * 2022-09-30 2022-11-16 Imperial College Innovations Ltd Biomolecules in disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
ATE426174T1 (en) * 2006-07-28 2009-04-15 Vista Ventures Gmbh METHOD FOR DETECTING AMYLOID-BETA OLIGOMERS IN BODY FLUIDS
US20120190652A1 (en) * 2009-09-16 2012-07-26 United Arab Emirates University Diagnostic agent for parkinson's disease

Also Published As

Publication number Publication date
WO2016001644A1 (en) 2016-01-07

Similar Documents

Publication Publication Date Title
ZA201901279B (en) Compositions and methods for treatment of neurological disorders
IL252839A0 (en) Treatment of pemphigus
PT3212233T (en) Combination therapy for treatment of disease
GB201701673D0 (en) Methods of well treatment
EP3104776A4 (en) Diagnosis and treatment of respiratory disorders
IL262852A (en) Treatment of complement-mediated disorders
HK1244711A1 (en) Treatment of hmgb1-mediated inflammation
EP3068492A4 (en) Neurodegenerative disorders and methods of treatment and diagnosis thereof
GB201516905D0 (en) Treatment of Neurodegenerative diseases
HK1231386A1 (en) Treatment of immune disorders
PL3160464T3 (en) 6-hydroxybuspirone for use in the treatment of movement disorders
GB201408387D0 (en) Treatment of respiratory disorders
GB201416832D0 (en) Methods of treatment
GB201412578D0 (en) Treatment of neurological diseases
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
EP3193870A4 (en) Treatment of neurodegenerative diseases with combination of laquinimod and fingolimod
GB201607388D0 (en) Treatment of impulsivity-related disorders
SG10201913129QA (en) Treatment and diagnosis of inflammatory disorders
GB201411616D0 (en) Diagnosis and treatment of neurodegenerative disorders
LT3137093T (en) Treatment and prevention of alzheimer`s disease (ad)
GB201510676D0 (en) Novel diagnostic and therapeutic method
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201417248D0 (en) Compostion and methods of treatment
HK1252359A1 (en) Combination of trazodone and gabapentin for the treatment of pain
HK1246271A1 (en) Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)